Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prothrombin Complex Concentrate in Hemophilia B
CTR20160937Phase 3Completed
- Sponsor
- Nanyue Biopharmaceutical
- Start
- Nov 2016
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of balfaxar in hemophilia B (HB), Congenital Prothrombin Deficiency, congenital factor VII deficiency, congenital factor X deficiency, prothrombin deficiency, sponsored by Nanyue Biopharmaceutical. Started Nov 2016; status: completed.
02
Drugs
balfaxar
03
Conditions
hemophilia B (HB)Congenital Prothrombin Deficiencycongenital factor VII deficiencycongenital factor X deficiencyprothrombin deficiency
Beyond the preview
Go deeper on CTR20160937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160937.